SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-10-002502
Filing Date
2010-08-13
Accepted
2010-08-13 07:10:49
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT slxcf_10q.htm 10-Q 699201
2 CERTIFICATION slxcf_ex311.htm EX-31.1 14938
3 CERTIFICATION slxcf_ex312.htm EX-31.2 14383
4 CERTIFICATION slxcf_ex321.htm EX-32.1 6009
5 CERTIFICATION slxcf_ex322.htm EX-32.2 6402
  Complete submission text file 0001354488-10-002502.txt   742392
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 101012877
SIC: 2834 Pharmaceutical Preparations